Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 7CNS 7Breast 7Thoracic 5Gastrointestinal 5Dermatologic 4Tumor-Agnostic 3Genitourinary 3Sarcoma 2Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Condylomata Acuminata 1Colorectal Neoplasms 1Colonic Neoplasms 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 765Gemcitabine 651Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 441Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 218pembrolizumab 206Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 181Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Vaccines × Gastrointestinal × Clear all
NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Active not recruiting
2 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06866574 2025-07-31

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Xiamen University

Phase 3 Active not recruiting
9,300 enrolled
Gastrointestinal

Anus Neoplasms, Condylomata Acuminata

NCT06522919 2025-01-28

CombiCoR-Vax

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting
36 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03946358 2024-12-20

VolATIL

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed
47 enrolled
GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

NCT01896869 2020-05-19

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
83 enrolled 16 charts
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡